COLUCID PHARMACEUTICALS
CoLucid Pharmaceuticals, Inc., a biotechnology company, focuses on therapies for central nervous system disorders. The company develops COL-144, a neurally acting anti-migraine agent, which is designed to treat migraine; and COL-204, a conjugated stigmine platform that produces novel chemical entities for therapy of sleep/wake disorders, chronic pain, Alzheimer's disease, and psychiatric disorders. CoLucid Pharmaceuticals was founded in 2005 and is based in Research Triangle Park, North Carolina.
COLUCID PHARMACEUTICALS
Industry:
Biotechnology Medical Device Pharmaceutical
Founded:
2005-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.colucid.com
Total Employee:
1+
Status:
Active
Contact:
(919) 649-6184
Email Addresses:
[email protected]
Total Funding:
97.3 M USD
Technology used in webpage:
Font Awesome Amazon Google Maps Google Maps API ASP.NET Amazon Ohio Region Ninja Forms Entrust EV Entrust SSL Omniture SiteCatalyst
Similar Organizations
![]()
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
![]()
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Current Advisors List
![]()
![]()
Current Employees Featured
![]()
![]()
![]()
Founder
![]()
Stock Details
Investors List
![]()
Domain Associates
Domain Associates investment in Series C - CoLucid Pharmaceuticals
TVM Capital Life Science
TVM Capital Life Science investment in Series C - CoLucid Pharmaceuticals
![]()
Novo Ventures
Novo Ventures investment in Series C - CoLucid Pharmaceuticals
![]()
Care Capital
Care Capital investment in Series C - CoLucid Pharmaceuticals
![]()
Auriga Partners
Auriga Partners investment in Series C - CoLucid Pharmaceuticals
![]()
Pearl Street Venture Funds
Pearl Street Venture Funds investment in Series C - CoLucid Pharmaceuticals
![]()
Pappas Ventures
Pappas Ventures investment in Series C - CoLucid Pharmaceuticals
![]()
Triathlon Medical Venture Partners
Triathlon Medical Venture Partners investment in Series C - CoLucid Pharmaceuticals
![]()
Domain Associates
Domain Associates investment in Venture Round - CoLucid Pharmaceuticals
![]()
Pappas Ventures
Pappas Ventures investment in Venture Round - CoLucid Pharmaceuticals
Official Site Inspections
http://www.colucid.com
- Host name: a4972715dfa2f21c3.awsglobalaccelerator.com
 - IP address: 75.2.103.146
 - Location: Seattle United States
 - Latitude: 47.54
 - Longitude: -122.3032
 - Metro Code: 819
 - Timezone: America/Los_Angeles
 - Postal: 98108
 
